 Robert Enzenauer
Concepts (545)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amblyopia | 7 | 2023 | 60 | 1.670 |
Why?
| | Ophthalmologic Surgical Procedures | 8 | 2019 | 91 | 1.430 |
Why?
| | Vision Screening | 4 | 2023 | 48 | 1.400 |
Why?
| | Retinopathy of Prematurity | 9 | 2021 | 183 | 1.310 |
Why?
| | Strabismus | 9 | 2017 | 71 | 1.160 |
Why?
| | Refractive Errors | 4 | 2023 | 36 | 1.140 |
Why?
| | Oculomotor Muscles | 11 | 2017 | 86 | 1.060 |
Why?
| | Cornea | 9 | 2021 | 156 | 1.050 |
Why?
| | Ophthalmology | 7 | 2026 | 121 | 1.000 |
Why?
| | Eye Injuries, Penetrating | 3 | 2013 | 19 | 0.750 |
Why?
| | Military Medicine | 4 | 2016 | 150 | 0.660 |
Why?
| | Eye Injuries | 8 | 2016 | 53 | 0.660 |
Why?
| | Eye Foreign Bodies | 3 | 2014 | 23 | 0.650 |
Why?
| | Military Personnel | 8 | 2018 | 749 | 0.630 |
Why?
| | Photography | 3 | 2010 | 120 | 0.610 |
Why?
| | Chemical Warfare Agents | 6 | 2021 | 89 | 0.610 |
Why?
| | Endophthalmitis | 5 | 2002 | 46 | 0.600 |
Why?
| | Patient Simulation | 1 | 2019 | 43 | 0.560 |
Why?
| | Exotropia | 4 | 2006 | 25 | 0.560 |
Why?
| | Lighting | 2 | 2016 | 31 | 0.550 |
Why?
| | Tensile Strength | 2 | 2017 | 98 | 0.550 |
Why?
| | Amnion | 1 | 2017 | 31 | 0.530 |
Why?
| | Equipment Design | 1 | 2019 | 527 | 0.500 |
Why?
| | Down Syndrome | 1 | 2023 | 526 | 0.480 |
Why?
| | Eye Infections, Bacterial | 3 | 2002 | 46 | 0.480 |
Why?
| | Teaching | 1 | 2019 | 242 | 0.470 |
Why?
| | Esotropia | 4 | 2006 | 30 | 0.470 |
Why?
| | Color Vision | 1 | 2016 | 4 | 0.470 |
Why?
| | Diagnostic Techniques, Ophthalmological | 3 | 2016 | 55 | 0.470 |
Why?
| | Color | 1 | 2016 | 81 | 0.460 |
Why?
| | Wound Healing | 3 | 2017 | 361 | 0.450 |
Why?
| | Delivery of Health Care | 2 | 2013 | 951 | 0.420 |
Why?
| | Neonatal Screening | 5 | 2021 | 185 | 0.420 |
Why?
| | Boxing | 5 | 1994 | 7 | 0.400 |
Why?
| | Ophthalmic Solutions | 5 | 2017 | 82 | 0.400 |
Why?
| | Tissue Adhesions | 2 | 2017 | 34 | 0.400 |
Why?
| | Humans | 118 | 2026 | 147293 | 0.380 |
Why?
| | Vitrectomy | 4 | 2007 | 74 | 0.380 |
Why?
| | Surgical Procedures, Operative | 1 | 2016 | 272 | 0.370 |
Why?
| | Visual Acuity | 11 | 2013 | 498 | 0.360 |
Why?
| | Retinoscopes | 1 | 2011 | 1 | 0.330 |
Why?
| | Rabbits | 8 | 2021 | 654 | 0.330 |
Why?
| | Insurance, Liability | 1 | 2010 | 8 | 0.320 |
Why?
| | Dacryocystitis | 1 | 2010 | 5 | 0.320 |
Why?
| | Mucocele | 1 | 2010 | 12 | 0.320 |
Why?
| | Mustard Gas | 3 | 2021 | 77 | 0.320 |
Why?
| | Nonprescription Drugs | 2 | 2003 | 69 | 0.310 |
Why?
| | Pupil Disorders | 1 | 2010 | 7 | 0.310 |
Why?
| | Corneal Injuries | 2 | 2021 | 42 | 0.300 |
Why?
| | Reimbursement Mechanisms | 1 | 2010 | 79 | 0.300 |
Why?
| | Conjunctival Diseases | 2 | 2017 | 23 | 0.300 |
Why?
| | Infant, Newborn | 27 | 2021 | 6543 | 0.300 |
Why?
| | Surveys and Questionnaires | 9 | 2026 | 6164 | 0.300 |
Why?
| | Warfare | 3 | 2018 | 100 | 0.290 |
Why?
| | Sensitivity and Specificity | 6 | 2023 | 2017 | 0.290 |
Why?
| | Mechlorethamine | 3 | 2019 | 52 | 0.280 |
Why?
| | Decompression, Surgical | 3 | 2019 | 117 | 0.280 |
Why?
| | Corneal Neovascularization | 3 | 2017 | 15 | 0.270 |
Why?
| | Vitreous Detachment | 1 | 2007 | 6 | 0.270 |
Why?
| | Developmental Disabilities | 1 | 2011 | 284 | 0.260 |
Why?
| | Optic Neuropathy, Ischemic | 1 | 2007 | 31 | 0.260 |
Why?
| | Optic Disk | 1 | 2007 | 53 | 0.250 |
Why?
| | Vitreous Body | 1 | 2007 | 118 | 0.250 |
Why?
| | Arsenicals | 2 | 2017 | 28 | 0.250 |
Why?
| | Birth Weight | 5 | 2017 | 522 | 0.250 |
Why?
| | Circumcision, Male | 5 | 1987 | 16 | 0.250 |
Why?
| | Ophthalmologists | 1 | 2026 | 21 | 0.240 |
Why?
| | Weight Gain | 3 | 2016 | 566 | 0.240 |
Why?
| | Photorefractive Keratectomy | 1 | 2006 | 21 | 0.240 |
Why?
| | Horner Syndrome | 1 | 2006 | 7 | 0.230 |
Why?
| | Orbit | 3 | 2013 | 67 | 0.230 |
Why?
| | Choristoma | 1 | 2006 | 20 | 0.230 |
Why?
| | Infant | 25 | 2017 | 10194 | 0.230 |
Why?
| | Indans | 1 | 2005 | 13 | 0.230 |
Why?
| | Corneal Transplantation | 2 | 2005 | 17 | 0.230 |
Why?
| | Nootropic Agents | 1 | 2005 | 30 | 0.220 |
Why?
| | Glaucoma, Angle-Closure | 1 | 2005 | 23 | 0.220 |
Why?
| | Neck | 1 | 2006 | 109 | 0.220 |
Why?
| | Hypergammaglobulinemia | 2 | 1999 | 8 | 0.220 |
Why?
| | Cataract Extraction | 3 | 2002 | 120 | 0.220 |
Why?
| | Retinal Hemorrhage | 5 | 2013 | 22 | 0.220 |
Why?
| | Keratomileusis, Laser In Situ | 1 | 2005 | 20 | 0.220 |
Why?
| | Predictive Value of Tests | 3 | 2023 | 2133 | 0.210 |
Why?
| | Thymus Gland | 1 | 2006 | 313 | 0.210 |
Why?
| | Mathematical Computing | 1 | 2004 | 11 | 0.210 |
Why?
| | Vitamin A Deficiency | 1 | 2004 | 26 | 0.210 |
Why?
| | Ocular Motility Disorders | 2 | 2003 | 42 | 0.210 |
Why?
| | Contact Lenses, Hydrophilic | 2 | 1997 | 7 | 0.200 |
Why?
| | Multiple Sclerosis | 1 | 2010 | 491 | 0.200 |
Why?
| | Orbital Fractures | 1 | 2004 | 14 | 0.200 |
Why?
| | Retinal Detachment | 2 | 2002 | 74 | 0.200 |
Why?
| | Vision, Ocular | 2 | 2016 | 47 | 0.200 |
Why?
| | Piperidines | 1 | 2005 | 224 | 0.200 |
Why?
| | Child | 17 | 2023 | 22979 | 0.200 |
Why?
| | Corneal Diseases | 2 | 2015 | 48 | 0.190 |
Why?
| | Diplopia | 1 | 2003 | 28 | 0.190 |
Why?
| | Suture Techniques | 3 | 1999 | 138 | 0.180 |
Why?
| | Dry Eye Syndromes | 1 | 2003 | 56 | 0.180 |
Why?
| | Eyelids | 3 | 2013 | 41 | 0.180 |
Why?
| | Drug Costs | 1 | 2003 | 117 | 0.180 |
Why?
| | Astigmatism | 2 | 2011 | 17 | 0.180 |
Why?
| | Risk Factors | 9 | 2023 | 11017 | 0.180 |
Why?
| | Intraocular Pressure | 6 | 2013 | 332 | 0.180 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3448 | 0.180 |
Why?
| | Physical Examination | 1 | 2023 | 245 | 0.180 |
Why?
| | Granuloma, Foreign-Body | 1 | 2002 | 8 | 0.180 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2003 | 242 | 0.180 |
Why?
| | Blepharoptosis | 1 | 2002 | 13 | 0.180 |
Why?
| | Sclerostomy | 1 | 2001 | 4 | 0.180 |
Why?
| | Oculomotor Nerve Diseases | 1 | 2002 | 14 | 0.180 |
Why?
| | Abducens Nerve Diseases | 1 | 2002 | 13 | 0.170 |
Why?
| | Myopia | 2 | 2011 | 59 | 0.170 |
Why?
| | Epithelium, Corneal | 3 | 2017 | 41 | 0.170 |
Why?
| | Male | 54 | 2020 | 73950 | 0.170 |
Why?
| | Female | 47 | 2017 | 80076 | 0.170 |
Why?
| | Echolalia | 1 | 2001 | 1 | 0.170 |
Why?
| | Vigabatrin | 1 | 2021 | 19 | 0.170 |
Why?
| | Aniridia | 1 | 2020 | 5 | 0.160 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2001 | 14 | 0.160 |
Why?
| | PAX6 Transcription Factor | 1 | 2020 | 21 | 0.160 |
Why?
| | Trabeculectomy | 1 | 2001 | 75 | 0.160 |
Why?
| | Hospitalization | 3 | 2010 | 2496 | 0.160 |
Why?
| | Child, Preschool | 17 | 2020 | 12016 | 0.160 |
Why?
| | Arthritis | 3 | 2017 | 97 | 0.160 |
Why?
| | Immunoglobulin G | 2 | 1999 | 901 | 0.160 |
Why?
| | Tissue Donors | 2 | 2005 | 427 | 0.160 |
Why?
| | Codon, Nonsense | 1 | 2020 | 45 | 0.160 |
Why?
| | Retinal Diseases | 5 | 1994 | 101 | 0.160 |
Why?
| | Infant, Low Birth Weight | 2 | 2017 | 156 | 0.160 |
Why?
| | Eye Proteins | 1 | 2020 | 93 | 0.160 |
Why?
| | Cyclooxygenase 2 | 5 | 2021 | 167 | 0.160 |
Why?
| | Glaucoma, Open-Angle | 1 | 2001 | 105 | 0.160 |
Why?
| | Socioeconomic Factors | 3 | 2021 | 1342 | 0.150 |
Why?
| | Scleral Buckling | 1 | 1999 | 16 | 0.150 |
Why?
| | Drug Residues | 1 | 1999 | 3 | 0.150 |
Why?
| | Leadership | 1 | 2004 | 409 | 0.150 |
Why?
| | Wilms Tumor | 1 | 2020 | 90 | 0.150 |
Why?
| | Corneal Stroma | 2 | 2017 | 24 | 0.150 |
Why?
| | Sclera | 1 | 1999 | 38 | 0.150 |
Why?
| | Organ Preservation Solutions | 1 | 1999 | 46 | 0.150 |
Why?
| | Prospective Studies | 7 | 2019 | 8164 | 0.150 |
Why?
| | Lacrimal Apparatus | 1 | 2019 | 11 | 0.140 |
Why?
| | Immunoglobulin lambda-Chains | 1 | 1999 | 9 | 0.140 |
Why?
| | Paraproteinemias | 1 | 1999 | 5 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2019 | 4604 | 0.140 |
Why?
| | Retinal Vein Occlusion | 1 | 1999 | 14 | 0.140 |
Why?
| | Functional Laterality | 2 | 2010 | 241 | 0.140 |
Why?
| | Attitude of Health Personnel | 3 | 2026 | 1220 | 0.140 |
Why?
| | Pneumococcal Infections | 1 | 1999 | 106 | 0.140 |
Why?
| | Face | 1 | 2020 | 176 | 0.140 |
Why?
| | Staphylococcal Infections | 3 | 2011 | 395 | 0.140 |
Why?
| | Contrast Sensitivity | 1 | 2018 | 15 | 0.140 |
Why?
| | Vision Tests | 1 | 2018 | 22 | 0.140 |
Why?
| | Anticonvulsants | 1 | 2021 | 253 | 0.140 |
Why?
| | Color Perception | 1 | 2018 | 25 | 0.140 |
Why?
| | Organ Preservation | 1 | 1999 | 127 | 0.140 |
Why?
| | Postoperative Complications | 3 | 2017 | 3022 | 0.140 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2021 | 133 | 0.140 |
Why?
| | Naphazoline | 1 | 1997 | 1 | 0.130 |
Why?
| | Pheniramine | 1 | 1997 | 1 | 0.130 |
Why?
| | Retrobulbar Hemorrhage | 2 | 2009 | 4 | 0.130 |
Why?
| | Conjunctivitis, Allergic | 1 | 1997 | 4 | 0.130 |
Why?
| | United States | 13 | 2021 | 16313 | 0.130 |
Why?
| | Nasal Decongestants | 1 | 1997 | 9 | 0.130 |
Why?
| | Histamine H1 Antagonists | 1 | 1997 | 24 | 0.130 |
Why?
| | Mydriasis | 1 | 1997 | 10 | 0.130 |
Why?
| | Adolescent | 16 | 2016 | 22825 | 0.130 |
Why?
| | Nerve Agents | 1 | 2017 | 7 | 0.130 |
Why?
| | Atropine | 1 | 2017 | 37 | 0.130 |
Why?
| | Gestational Age | 6 | 2017 | 997 | 0.130 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 124 | 0.130 |
Why?
| | Conjunctiva | 1 | 2017 | 52 | 0.130 |
Why?
| | Farber Lipogranulomatosis | 1 | 2017 | 4 | 0.130 |
Why?
| | Meningitis | 3 | 1983 | 80 | 0.130 |
Why?
| | Athletic Injuries | 3 | 1989 | 576 | 0.130 |
Why?
| | Antimetabolites | 1 | 1997 | 21 | 0.130 |
Why?
| | Drug Therapy, Combination | 5 | 2012 | 1046 | 0.120 |
Why?
| | Synovitis | 1 | 2017 | 35 | 0.120 |
Why?
| | Telemedicine | 1 | 2026 | 978 | 0.120 |
Why?
| | Quality Indicators, Health Care | 1 | 1999 | 337 | 0.120 |
Why?
| | Adult | 21 | 2018 | 41405 | 0.120 |
Why?
| | Cicatrix | 1 | 1997 | 72 | 0.120 |
Why?
| | Orbital Neoplasms | 2 | 1993 | 28 | 0.120 |
Why?
| | Swine | 1 | 2019 | 828 | 0.120 |
Why?
| | False Positive Reactions | 2 | 2011 | 124 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 587 | 0.120 |
Why?
| | Retrospective Studies | 15 | 2021 | 17560 | 0.120 |
Why?
| | Kidney Neoplasms | 1 | 2020 | 421 | 0.120 |
Why?
| | Infant, Newborn, Diseases | 3 | 1982 | 116 | 0.120 |
Why?
| | Fluorouracil | 1 | 1997 | 232 | 0.120 |
Why?
| | Health Personnel | 2 | 2000 | 762 | 0.110 |
Why?
| | Antidotes | 1 | 2017 | 145 | 0.110 |
Why?
| | Uveitis | 1 | 2017 | 151 | 0.110 |
Why?
| | Educational Measurement | 1 | 2019 | 332 | 0.110 |
Why?
| | Afghanistan | 2 | 2007 | 97 | 0.110 |
Why?
| | Convergence, Ocular | 1 | 1995 | 6 | 0.110 |
Why?
| | Visual Fields | 3 | 2007 | 116 | 0.110 |
Why?
| | Treatment Outcome | 10 | 2011 | 11947 | 0.110 |
Why?
| | Household Products | 1 | 2015 | 6 | 0.110 |
Why?
| | Fibrosis | 1 | 2017 | 568 | 0.110 |
Why?
| | Eye Burns | 1 | 2015 | 14 | 0.110 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 318 | 0.110 |
Why?
| | Burns, Chemical | 1 | 2015 | 33 | 0.110 |
Why?
| | Public Health | 1 | 2000 | 577 | 0.110 |
Why?
| | Ethanol | 1 | 1999 | 634 | 0.110 |
Why?
| | Algorithms | 3 | 2017 | 1868 | 0.100 |
Why?
| | Quality of Health Care | 1 | 1999 | 697 | 0.100 |
Why?
| | Interleukin-8 | 3 | 2021 | 269 | 0.100 |
Why?
| | Animals | 9 | 2021 | 38410 | 0.100 |
Why?
| | Keratitis | 2 | 2017 | 21 | 0.100 |
Why?
| | Slit Lamp | 1 | 2014 | 3 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 6 | 2010 | 3980 | 0.100 |
Why?
| | Hyphema | 1 | 2013 | 7 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 4 | 2019 | 552 | 0.100 |
Why?
| | Keratotomy, Radial | 1 | 1993 | 10 | 0.100 |
Why?
| | Lymphangioma | 1 | 1993 | 9 | 0.100 |
Why?
| | Health Care Surveys | 2 | 2010 | 538 | 0.100 |
Why?
| | Blindness | 2 | 2009 | 51 | 0.100 |
Why?
| | Scleral Diseases | 1 | 1992 | 2 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2002 | 1107 | 0.090 |
Why?
| | Staphylococcus | 2 | 2011 | 74 | 0.090 |
Why?
| | DNA Damage | 1 | 2016 | 440 | 0.090 |
Why?
| | Abducens Nerve | 1 | 1992 | 3 | 0.090 |
Why?
| | Skull Neoplasms | 1 | 1992 | 22 | 0.090 |
Why?
| | Eye Infections, Fungal | 1 | 1992 | 20 | 0.090 |
Why?
| | Dura Mater | 1 | 1992 | 40 | 0.090 |
Why?
| | Anesthetics, Dissociative | 1 | 2012 | 47 | 0.090 |
Why?
| | Opportunistic Infections | 1 | 1992 | 47 | 0.090 |
Why?
| | Glucocorticoids | 4 | 2017 | 537 | 0.090 |
Why?
| | Cranial Nerve Diseases | 1 | 1992 | 44 | 0.090 |
Why?
| | Hospitals, Military | 3 | 2007 | 29 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 4351 | 0.090 |
Why?
| | Doxycycline | 1 | 2012 | 62 | 0.090 |
Why?
| | Paralysis | 1 | 1992 | 69 | 0.090 |
Why?
| | Child Abuse | 3 | 2013 | 558 | 0.090 |
Why?
| | Craniocerebral Trauma | 3 | 2013 | 180 | 0.090 |
Why?
| | Foreign Bodies | 1 | 2013 | 110 | 0.090 |
Why?
| | Follow-Up Studies | 8 | 2011 | 5476 | 0.080 |
Why?
| | Double-Blind Method | 2 | 2011 | 2080 | 0.080 |
Why?
| | Vision, Binocular | 4 | 2005 | 47 | 0.080 |
Why?
| | Cyclophosphamide | 2 | 2003 | 277 | 0.080 |
Why?
| | Silymarin | 1 | 2012 | 147 | 0.080 |
Why?
| | Anisometropia | 1 | 2011 | 18 | 0.080 |
Why?
| | Hyperopia | 1 | 2011 | 19 | 0.080 |
Why?
| | Ketamine | 1 | 2012 | 141 | 0.080 |
Why?
| | Orbital Cellulitis | 1 | 2011 | 17 | 0.080 |
Why?
| | Facial Pain | 1 | 1990 | 12 | 0.080 |
Why?
| | Gingivitis | 1 | 1990 | 13 | 0.080 |
Why?
| | Drug Industry | 1 | 1990 | 49 | 0.080 |
Why?
| | Middle Aged | 13 | 2016 | 36821 | 0.080 |
Why?
| | Corneal Keratocytes | 2 | 2021 | 8 | 0.080 |
Why?
| | Dexamethasone | 1 | 2012 | 368 | 0.080 |
Why?
| | Malpractice | 1 | 2010 | 44 | 0.080 |
Why?
| | Fat Emulsions, Intravenous | 1 | 1990 | 29 | 0.080 |
Why?
| | Light | 1 | 2013 | 403 | 0.080 |
Why?
| | Retina | 3 | 2021 | 331 | 0.080 |
Why?
| | Immunoglobulin Light Chains | 1 | 1990 | 52 | 0.080 |
Why?
| | Aged | 13 | 2016 | 26514 | 0.070 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2013 | 339 | 0.070 |
Why?
| | Incidental Findings | 1 | 2010 | 82 | 0.070 |
Why?
| | Anti-Bacterial Agents | 4 | 2012 | 1940 | 0.070 |
Why?
| | Aerospace Medicine | 3 | 2014 | 32 | 0.070 |
Why?
| | Anti-Infective Agents | 2 | 2002 | 234 | 0.070 |
Why?
| | Fluorescein Angiography | 4 | 1999 | 193 | 0.070 |
Why?
| | Retinal Vessels | 1 | 1990 | 79 | 0.070 |
Why?
| | Nocardia Infections | 1 | 1989 | 11 | 0.070 |
Why?
| | Corneal Ulcer | 2 | 2004 | 21 | 0.070 |
Why?
| | Incidence | 4 | 2013 | 2954 | 0.070 |
Why?
| | Blood Vessels | 2 | 2021 | 167 | 0.070 |
Why?
| | Color Perception Tests | 1 | 2007 | 3 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 392 | 0.070 |
Why?
| | Enteral Nutrition | 1 | 1990 | 218 | 0.070 |
Why?
| | Autopsy | 1 | 2007 | 96 | 0.060 |
Why?
| | Urinary Tract Infections | 2 | 1987 | 212 | 0.060 |
Why?
| | Sudden Infant Death | 1 | 2007 | 40 | 0.060 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 840 | 0.060 |
Why?
| | Fundus Oculi | 6 | 1994 | 89 | 0.060 |
Why?
| | Eye Movements | 3 | 2005 | 94 | 0.060 |
Why?
| | Shaken Baby Syndrome | 1 | 2006 | 5 | 0.060 |
Why?
| | Accidents, Traffic | 2 | 2013 | 195 | 0.060 |
Why?
| | Chromosome Inversion | 1 | 1986 | 20 | 0.060 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 1986 | 50 | 0.060 |
Why?
| | Prevalence | 2 | 2013 | 2889 | 0.060 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2006 | 11 | 0.060 |
Why?
| | Nasolacrimal Duct | 1 | 2006 | 12 | 0.060 |
Why?
| | Videotape Recording | 1 | 1986 | 37 | 0.060 |
Why?
| | Infant, Very Low Birth Weight | 2 | 2017 | 76 | 0.060 |
Why?
| | Lasers, Excimer | 1 | 2006 | 30 | 0.060 |
Why?
| | Refraction, Ocular | 1 | 2006 | 47 | 0.060 |
Why?
| | Optic Nerve Diseases | 1 | 2006 | 49 | 0.060 |
Why?
| | Time Factors | 4 | 2017 | 7173 | 0.060 |
Why?
| | Health Surveys | 2 | 2006 | 522 | 0.060 |
Why?
| | Parenteral Nutrition, Total | 1 | 1985 | 30 | 0.060 |
Why?
| | Skin Diseases, Infectious | 1 | 1985 | 13 | 0.060 |
Why?
| | Cell Survival | 2 | 2021 | 1111 | 0.060 |
Why?
| | Chromosome Aberrations | 1 | 1986 | 168 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2006 | 1518 | 0.060 |
Why?
| | Quality Control | 1 | 2006 | 161 | 0.060 |
Why?
| | Tomography, Optical Coherence | 1 | 2007 | 275 | 0.060 |
Why?
| | Colorado | 4 | 2017 | 4591 | 0.060 |
Why?
| | Smoking Prevention | 1 | 1986 | 167 | 0.060 |
Why?
| | Refractive Surgical Procedures | 1 | 2005 | 7 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 1992 | 928 | 0.050 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 986 | 0.050 |
Why?
| | Pyoderma | 1 | 1984 | 3 | 0.050 |
Why?
| | Ethics | 1 | 2004 | 5 | 0.050 |
Why?
| | Night Blindness | 1 | 2004 | 6 | 0.050 |
Why?
| | Myxoma | 1 | 1984 | 11 | 0.050 |
Why?
| | Reoperation | 3 | 1999 | 644 | 0.050 |
Why?
| | Xerophthalmia | 1 | 2004 | 7 | 0.050 |
Why?
| | Mitral Valve Stenosis | 1 | 1984 | 20 | 0.050 |
Why?
| | Intellectual Disability | 1 | 1986 | 183 | 0.050 |
Why?
| | Organizational Objectives | 1 | 2004 | 67 | 0.050 |
Why?
| | Heart Neoplasms | 1 | 1984 | 56 | 0.050 |
Why?
| | Chloramphenicol | 1 | 1983 | 11 | 0.050 |
Why?
| | Theophylline | 1 | 1984 | 41 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 1986 | 227 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2006 | 369 | 0.050 |
Why?
| | Ampicillin | 1 | 1983 | 17 | 0.050 |
Why?
| | Esophageal Diseases | 1 | 1984 | 30 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2005 | 312 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2019 | 1730 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 481 | 0.050 |
Why?
| | Preservatives, Pharmaceutical | 1 | 2003 | 28 | 0.050 |
Why?
| | Drug Packaging | 1 | 2003 | 41 | 0.050 |
Why?
| | Syndrome | 3 | 2020 | 385 | 0.050 |
Why?
| | Corneal Opacity | 2 | 2016 | 8 | 0.050 |
Why?
| | Pleura | 1 | 1983 | 28 | 0.050 |
Why?
| | Intermittent Positive-Pressure Ventilation | 1 | 1983 | 12 | 0.050 |
Why?
| | Cholestasis | 1 | 1985 | 217 | 0.050 |
Why?
| | Illinois | 2 | 2000 | 50 | 0.050 |
Why?
| | Cross Infection | 1 | 1985 | 261 | 0.050 |
Why?
| | Femoral Fractures | 2 | 1992 | 84 | 0.050 |
Why?
| | Counseling | 1 | 1986 | 407 | 0.050 |
Why?
| | Methylprednisolone | 1 | 2003 | 59 | 0.050 |
Why?
| | Drug Combinations | 2 | 1997 | 399 | 0.050 |
Why?
| | Citrobacter | 1 | 1982 | 3 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 2 | 2010 | 1379 | 0.050 |
Why?
| | Diagnostic Imaging | 1 | 2005 | 342 | 0.040 |
Why?
| | Abducens Nerve Injury | 1 | 2002 | 1 | 0.040 |
Why?
| | Oculomotor Nerve Injuries | 1 | 2002 | 2 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 1983 | 116 | 0.040 |
Why?
| | Cohort Studies | 3 | 2017 | 6099 | 0.040 |
Why?
| | Enterobacteriaceae Infections | 1 | 1982 | 43 | 0.040 |
Why?
| | Radiography, Thoracic | 1 | 1983 | 173 | 0.040 |
Why?
| | Pectoralis Muscles | 1 | 1981 | 18 | 0.040 |
Why?
| | Young Adult | 2 | 2016 | 14437 | 0.040 |
Why?
| | Electroretinography | 1 | 2021 | 51 | 0.040 |
Why?
| | Hydrocephalus | 1 | 1982 | 114 | 0.040 |
Why?
| | Tibial Fractures | 1 | 1982 | 75 | 0.040 |
Why?
| | Medical Records | 1 | 2001 | 192 | 0.040 |
Why?
| | Parents | 2 | 2006 | 1428 | 0.040 |
Why?
| | Patient Education as Topic | 2 | 2003 | 781 | 0.040 |
Why?
| | Infant, Premature | 2 | 2017 | 635 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2005 | 2973 | 0.040 |
Why?
| | Cataract | 1 | 2003 | 238 | 0.040 |
Why?
| | Steroids | 1 | 2001 | 162 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 594 | 0.040 |
Why?
| | Eosinophilia | 1 | 1982 | 224 | 0.040 |
Why?
| | Appendicitis | 1 | 1982 | 153 | 0.040 |
Why?
| | Acute Disease | 2 | 2019 | 1049 | 0.040 |
Why?
| | Administration, Oral | 2 | 2017 | 874 | 0.040 |
Why?
| | Risk | 3 | 1989 | 927 | 0.040 |
Why?
| | Therapeutic Irrigation | 1 | 1999 | 69 | 0.040 |
Why?
| | Chlorambucil | 1 | 1999 | 11 | 0.040 |
Why?
| | Vitreous Hemorrhage | 1 | 1999 | 10 | 0.040 |
Why?
| | Colon | 1 | 1982 | 310 | 0.040 |
Why?
| | Leukemia | 1 | 1981 | 247 | 0.040 |
Why?
| | Sodium Chloride | 1 | 1999 | 138 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2005 | 639 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 4 | 1999 | 2791 | 0.030 |
Why?
| | Physical Therapy Modalities | 1 | 1982 | 346 | 0.030 |
Why?
| | Corneal Pachymetry | 1 | 2017 | 16 | 0.030 |
Why?
| | Lens, Crystalline | 1 | 1999 | 136 | 0.030 |
Why?
| | Prednisone | 1 | 1999 | 230 | 0.030 |
Why?
| | Blister | 1 | 2017 | 39 | 0.030 |
Why?
| | Streptococcus pneumoniae | 1 | 1999 | 190 | 0.030 |
Why?
| | Fluorometholone | 1 | 2017 | 4 | 0.030 |
Why?
| | Risk Assessment | 2 | 2017 | 3784 | 0.030 |
Why?
| | Administration, Intranasal | 1 | 2017 | 94 | 0.030 |
Why?
| | Hereditary Autoinflammatory Diseases | 1 | 2017 | 13 | 0.030 |
Why?
| | Biological Availability | 1 | 2017 | 146 | 0.030 |
Why?
| | Optometry | 1 | 1997 | 9 | 0.030 |
Why?
| | Bone Marrow | 1 | 1999 | 310 | 0.030 |
Why?
| | Brain | 1 | 2010 | 3009 | 0.030 |
Why?
| | Intraoperative Period | 1 | 1997 | 69 | 0.030 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2017 | 34 | 0.030 |
Why?
| | Body Weight | 1 | 2001 | 976 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2018 | 203 | 0.030 |
Why?
| | Administration, Topical | 1 | 1997 | 156 | 0.030 |
Why?
| | Quality of Life | 2 | 2006 | 3246 | 0.030 |
Why?
| | Laser Coagulation | 1 | 2017 | 80 | 0.030 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2016 | 24 | 0.030 |
Why?
| | Battered Child Syndrome | 2 | 1992 | 7 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2004 | 1598 | 0.030 |
Why?
| | Rupture | 1 | 2016 | 91 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 154 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2016 | 162 | 0.030 |
Why?
| | Apoptosis | 2 | 2016 | 2454 | 0.030 |
Why?
| | Prognosis | 3 | 2020 | 4383 | 0.030 |
Why?
| | Uveomeningoencephalitic Syndrome | 1 | 1995 | 7 | 0.030 |
Why?
| | Eye | 1 | 2016 | 112 | 0.030 |
Why?
| | Sarcoidosis | 1 | 2017 | 164 | 0.030 |
Why?
| | Surgical Wound Dehiscence | 1 | 1994 | 22 | 0.030 |
Why?
| | Scotoma | 1 | 1994 | 6 | 0.030 |
Why?
| | Agenesis of Corpus Callosum | 1 | 1994 | 13 | 0.030 |
Why?
| | Choroid Diseases | 1 | 1994 | 10 | 0.030 |
Why?
| | Choroiditis | 1 | 1994 | 6 | 0.030 |
Why?
| | Pilot Projects | 1 | 2000 | 1912 | 0.030 |
Why?
| | Accidents, Home | 1 | 2013 | 33 | 0.020 |
Why?
| | Ophthalmoplegia | 1 | 1993 | 13 | 0.020 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 302 | 0.020 |
Why?
| | Nerve Fibers, Myelinated | 1 | 1993 | 48 | 0.020 |
Why?
| | Contraindications | 1 | 1993 | 90 | 0.020 |
Why?
| | Facial Paralysis | 1 | 1993 | 23 | 0.020 |
Why?
| | Tamoxifen | 1 | 1994 | 193 | 0.020 |
Why?
| | Blotting, Western | 1 | 2016 | 1186 | 0.020 |
Why?
| | Iris | 1 | 1993 | 23 | 0.020 |
Why?
| | Dark Adaptation | 1 | 2013 | 13 | 0.020 |
Why?
| | Aviation | 1 | 2013 | 10 | 0.020 |
Why?
| | Surgery, Plastic | 1 | 1994 | 53 | 0.020 |
Why?
| | Fungemia | 1 | 1992 | 10 | 0.020 |
Why?
| | Ocular Physiological Phenomena | 1 | 1992 | 10 | 0.020 |
Why?
| | Cranial Fossa, Posterior | 1 | 1992 | 20 | 0.020 |
Why?
| | Aspergillosis | 1 | 1992 | 24 | 0.020 |
Why?
| | Mass Screening | 1 | 2021 | 1375 | 0.020 |
Why?
| | Candidiasis | 1 | 1992 | 64 | 0.020 |
Why?
| | Irritants | 1 | 2012 | 42 | 0.020 |
Why?
| | Eye Diseases | 1 | 1993 | 98 | 0.020 |
Why?
| | Emergencies | 2 | 2009 | 175 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 677 | 0.020 |
Why?
| | Mycoses | 1 | 1992 | 88 | 0.020 |
Why?
| | Heparin | 1 | 2013 | 249 | 0.020 |
Why?
| | Vision Disparity | 1 | 1991 | 4 | 0.020 |
Why?
| | Vision Disorders | 1 | 1993 | 179 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2030 | 0.020 |
Why?
| | Radiography | 3 | 1985 | 862 | 0.020 |
Why?
| | Thrombocytopenia | 1 | 2013 | 207 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2018 | 691 | 0.020 |
Why?
| | Sex Factors | 3 | 1987 | 2136 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1049 | 0.020 |
Why?
| | Coloboma | 1 | 1990 | 5 | 0.020 |
Why?
| | Pigment Epithelium of Eye | 1 | 1990 | 36 | 0.020 |
Why?
| | Retinal Perforations | 1 | 1990 | 18 | 0.020 |
Why?
| | Safflower Oil | 1 | 1990 | 4 | 0.020 |
Why?
| | Crohn Disease | 1 | 1994 | 262 | 0.020 |
Why?
| | Light Coagulation | 1 | 1990 | 10 | 0.020 |
Why?
| | Soybean Oil | 1 | 1990 | 15 | 0.020 |
Why?
| | Aged, 80 and over | 4 | 2005 | 8430 | 0.020 |
Why?
| | Emulsions | 1 | 1990 | 59 | 0.020 |
Why?
| | Indians, North American | 1 | 1995 | 567 | 0.020 |
Why?
| | Sacroiliac Joint | 2 | 1994 | 37 | 0.020 |
Why?
| | HEPES | 1 | 1989 | 2 | 0.020 |
Why?
| | Chondroitin | 1 | 1989 | 6 | 0.020 |
Why?
| | Tissue Preservation | 1 | 1989 | 11 | 0.020 |
Why?
| | Propionibacterium acnes | 1 | 1989 | 10 | 0.020 |
Why?
| | Lung | 1 | 1983 | 4141 | 0.020 |
Why?
| | Chondroitin Sulfates | 1 | 1989 | 35 | 0.020 |
Why?
| | Nocardia asteroides | 1 | 1989 | 1 | 0.020 |
Why?
| | Sulfacetamide | 1 | 1989 | 1 | 0.020 |
Why?
| | Trimethoprim | 1 | 1989 | 7 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 1989 | 7 | 0.020 |
Why?
| | Gentamicins | 1 | 1989 | 50 | 0.020 |
Why?
| | Graft Rejection | 1 | 1992 | 523 | 0.020 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 1989 | 43 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 1993 | 514 | 0.020 |
Why?
| | Antioxidants | 1 | 2012 | 550 | 0.020 |
Why?
| | Phospholipids | 1 | 1990 | 214 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1772 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2016 | 2529 | 0.020 |
Why?
| | Forensic Medicine | 1 | 2007 | 19 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 1990 | 222 | 0.020 |
Why?
| | Anticoagulants | 1 | 2013 | 751 | 0.020 |
Why?
| | Brain Injuries | 1 | 1992 | 508 | 0.020 |
Why?
| | Orbit Evisceration | 1 | 2006 | 1 | 0.020 |
Why?
| | Recurrence | 1 | 1990 | 1151 | 0.020 |
Why?
| | Forensic Pathology | 1 | 2006 | 10 | 0.020 |
Why?
| | Piperazines | 1 | 1989 | 375 | 0.020 |
Why?
| | Dacryocystorhinostomy | 1 | 2006 | 13 | 0.020 |
Why?
| | Hawaii | 1 | 1986 | 38 | 0.010 |
Why?
| | Sickness Impact Profile | 1 | 2006 | 67 | 0.010 |
Why?
| | Chromosome Disorders | 1 | 1986 | 47 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1986 | 164 | 0.010 |
Why?
| | Mutation | 1 | 2017 | 4130 | 0.010 |
Why?
| | Klebsiella pneumoniae | 1 | 1985 | 48 | 0.010 |
Why?
| | Wounds, Nonpenetrating | 1 | 2009 | 324 | 0.010 |
Why?
| | Informed Consent | 1 | 1986 | 200 | 0.010 |
Why?
| | Hirschsprung Disease | 1 | 1985 | 92 | 0.010 |
Why?
| | Tablets | 1 | 1984 | 41 | 0.010 |
Why?
| | Penicillin Resistance | 1 | 1983 | 9 | 0.010 |
Why?
| | Ulcer | 1 | 1984 | 37 | 0.010 |
Why?
| | Abdominal Muscles | 1 | 1983 | 12 | 0.010 |
Why?
| | Meningitis, Haemophilus | 1 | 1983 | 6 | 0.010 |
Why?
| | Mitral Valve | 1 | 1984 | 96 | 0.010 |
Why?
| | Arthritis, Infectious | 1 | 1985 | 77 | 0.010 |
Why?
| | Hernia, Umbilical | 1 | 1983 | 21 | 0.010 |
Why?
| | Arthritis, Rheumatoid | 1 | 1992 | 1183 | 0.010 |
Why?
| | Haemophilus influenzae | 1 | 1983 | 68 | 0.010 |
Why?
| | Length of Stay | 1 | 1989 | 1371 | 0.010 |
Why?
| | Health Services Misuse | 1 | 1983 | 35 | 0.010 |
Why?
| | Angiostrongylus | 1 | 1982 | 1 | 0.010 |
Why?
| | Nematode Infections | 1 | 1982 | 5 | 0.010 |
Why?
| | Age Distribution | 1 | 2003 | 406 | 0.010 |
Why?
| | Feces | 1 | 1985 | 500 | 0.010 |
Why?
| | Infant, Premature, Diseases | 1 | 1983 | 114 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2005 | 1302 | 0.010 |
Why?
| | Rupture, Spontaneous | 1 | 1982 | 15 | 0.010 |
Why?
| | Contracture | 1 | 1982 | 24 | 0.010 |
Why?
| | Kidney | 1 | 1990 | 1511 | 0.010 |
Why?
| | Leukemia, Lymphoid | 1 | 1981 | 27 | 0.010 |
Why?
| | Enema | 1 | 1982 | 46 | 0.010 |
Why?
| | Age Factors | 1 | 1989 | 3372 | 0.010 |
Why?
| | Elbow Joint | 1 | 1982 | 73 | 0.010 |
Why?
| | Glucagon | 1 | 1982 | 114 | 0.010 |
Why?
| | Regression Analysis | 1 | 2003 | 1003 | 0.010 |
Why?
| | Skin | 1 | 1985 | 759 | 0.010 |
Why?
| | Hip Joint | 1 | 1982 | 173 | 0.010 |
Why?
| | Contrast Media | 1 | 1982 | 500 | 0.010 |
Why?
| | Knee Joint | 1 | 1982 | 439 | 0.010 |
Why?
| | Spasm | 1 | 1994 | 21 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2006 | 6011 | 0.010 |
Why?
| | Spondylitis | 1 | 1994 | 1 | 0.010 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 1981 | 700 | 0.010 |
Why?
| | Sulfasalazine | 1 | 1994 | 22 | 0.010 |
Why?
| | Tenosynovitis | 1 | 1994 | 11 | 0.010 |
Why?
| | Crystallization | 1 | 1994 | 136 | 0.010 |
Why?
| | Middle East | 1 | 1993 | 18 | 0.010 |
Why?
| | Cadaver | 1 | 1994 | 316 | 0.010 |
Why?
| | Accommodation, Ocular | 1 | 1993 | 15 | 0.010 |
Why?
| | Rib Fractures | 1 | 1992 | 33 | 0.010 |
Why?
| | Posture | 1 | 1993 | 197 | 0.010 |
Why?
| | Muscles | 1 | 1993 | 330 | 0.010 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 1994 | 347 | 0.010 |
Why?
| | Reference Values | 1 | 1992 | 800 | 0.010 |
Why?
| | Drug Contamination | 1 | 1989 | 56 | 0.000 |
Why?
| | Culture Media | 1 | 1989 | 161 | 0.000 |
Why?
| | Postoperative Care | 1 | 1991 | 299 | 0.000 |
Why?
| | Macular Degeneration | 1 | 1990 | 196 | 0.000 |
Why?
| | Suppuration | 1 | 1985 | 9 | 0.000 |
Why?
| | Technetium Tc 99m Medronate | 1 | 1985 | 5 | 0.000 |
Why?
| | Gallium Radioisotopes | 1 | 1985 | 16 | 0.000 |
Why?
| | Radionuclide Imaging | 1 | 1985 | 116 | 0.000 |
Why?
| | Breast Neoplasms | 1 | 1994 | 2420 | 0.000 |
Why?
| | Aging | 1 | 1990 | 1992 | 0.000 |
Why?
| | Pediatrics | 1 | 1987 | 1139 | 0.000 |
Why?
|
|
Enzenauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|